Literature DB >> 392477

Chronic mucocutaneous candidiasis.

N Rosman.   

Abstract

The pathogenesis of chronic mucocutaneous candidiasis is surveyed. Treatment comprises topical antifungal treatment which is insufficient, systemic antifungal treatment which is often followed by a rapid relapse, and specific immunotherapy with live tissue or transfer factor. Combination of systemic antifungal therapy and immunotherapy seems to be the most promising approach. However, no permanent cure has so far been achieved.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 392477      PMCID： PMC2425665          DOI： 10.1136/pgmj.55.647.611

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  19 in total

1.  Miconazole in the treatment of chronic mucocutaneous candidiasis: a preliminary report.

Authors:  T J Fischer; R B Klein; H E Kershnar; T C Borut; E R Stiehm
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue.

Authors:  M Ballow; L R Hyman
Journal:  Clin Immunol Immunopathol       Date:  1977-11

3.  New syndrome of chronic mucocutaneous candidiasis.

Authors:  G A Okamoto; J G Hall; H Ochs; C Jackson; K Rodaway; J Chandler
Journal:  Birth Defects Orig Artic Ser       Date:  1977

4.  Thymic transplantation in a case of chronic mucocutaneous candidiasis.

Authors:  R L Levy; M L Bach; S Huang; F H Bach; R Hong; A J Ammann; M Bortin; H E Kay
Journal:  Lancet       Date:  1971-10-23       Impact factor: 79.321

5.  Lymphocyte abnormality in chronic mucocutaneous candidiasis.

Authors:  H Valdimarsson; L Holt; H R Riches; J R Hobbs
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

6.  Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow.

Authors:  R H Buckley; Z J Lucas; B G Hattler; C M Zmijewski; D B Amos
Journal:  Clin Exp Immunol       Date:  1968-02       Impact factor: 4.330

7.  Treatment of chronic mucocutaneous candidiasis.

Authors:  R H Meade
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

8.  Treatment of chronic mucocutaneous candidiasis with imidazole derivatives.

Authors:  F Lorente; G Fontan; M C Rodriguez; J A Ojeda
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

9.  An immunological investigation of a family with chronic mucocutaneous candidiasis.

Authors:  H Rothschild; M Wilson; M Lopez; J Salvaggio; D Bice
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

10.  Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis.

Authors:  M M Ipp; L Boxall; E W Gelfand
Journal:  Am J Dis Child       Date:  1977-03
View more
  3 in total

1.  Isolation and characterization of cell wall and cytoplasmic antigens and peripheral blood leukocyte responses in rabbits immunized with Candida albicans.

Authors:  Y E Shi
Journal:  Acta Acad Med Wuhan       Date:  1985

2.  Candida and "20th-century disease".

Authors:  B Zimmerman; E Weber
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

3.  Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole.

Authors:  Davide Firinu; Orietta Massidda; Maria Maddalena Lorrai; Loredana Serusi; Monica Peralta; Maria Pina Barca; Paolo Serra; Paolo Emilio Manconi
Journal:  Clin Dev Immunol       Date:  2010-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.